$6.85 Billion is the total value of RTW INVESTMENTS, LP's 124 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 46.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GH | Sell | GUARDANT HEALTH INC | $81,350,000 | -29.7% | 813,342 | -12.1% | 1.19% | -31.9% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $59,575,000 | -28.4% | 2,520,076 | -22.8% | 0.87% | -30.7% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $25,508,000 | -33.9% | 604,029 | -24.9% | 0.37% | -36.1% |
| JNJ | Sell | JOHNSON & JOHNSON | $21,405,000 | -22.3% | 125,127 | -26.6% | 0.31% | -24.6% |
| Sell | SIGHT SCIENCES INC | $20,801,000 | -28.6% | 1,183,871 | -7.8% | 0.30% | -30.9% | |
| AGEN | Sell | AGENUS INC | $18,896,000 | -60.3% | 5,868,315 | -35.3% | 0.28% | -61.6% |
| OLK | Sell | OLINK HLDG ABsponsored ads | $18,531,000 | -42.0% | 1,018,188 | -22.8% | 0.27% | -43.8% |
| CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $10,467,000 | -58.5% | 3,806,018 | -9.5% | 0.15% | -59.8% |
| OSUR | Sell | ORASURE TECHNOLOGIES INC | $10,032,000 | -24.5% | 1,154,380 | -1.7% | 0.15% | -27.0% |
| ABUS | Sell | ARBUTUS BIOPHARMA CORP | $9,742,000 | -52.0% | 2,504,493 | -47.1% | 0.14% | -53.6% |
| GTH | Sell | GENETRON HLDGS LTDads | $8,674,000 | -62.5% | 1,421,894 | -15.0% | 0.13% | -63.6% |
| VINC | Sell | VINCERX PHARMA INC | $7,553,000 | -37.7% | 741,236 | -1.2% | 0.11% | -39.9% |
| BMEA | Sell | BIOMEA FUSION INC | $4,424,000 | -55.2% | 593,846 | -28.5% | 0.06% | -56.4% |
| Sell | TANGO THERAPEUTICS INC | $1,978,000 | -74.5% | 180,819 | -69.9% | 0.03% | -75.2% | |
| RCEL | Sell | AVITA MEDICAL INC | $1,278,000 | -74.2% | 106,667 | -61.9% | 0.02% | -74.7% |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -30,000 | -100.0% | -0.01% | – |
| PROF | Exit | PROFOUND MED CORP | $0 | – | -122,098 | -100.0% | -0.03% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -18,473 | -100.0% | -0.03% | – |
| CVRX | Exit | CVRX INC | $0 | – | -150,000 | -100.0% | -0.04% | – |
| MAAC | Exit | MONTES ARCHIMEDES ACQUISITIO | $0 | – | -400,000 | -100.0% | -0.05% | – |
| AFIB | Exit | ACUTUS MED INC | $0 | – | -491,834 | -100.0% | -0.07% | – |
| APVO | Exit | APTEVO THERAPEUTICS INC | $0 | – | -281,402 | -100.0% | -0.07% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -257,546 | -100.0% | -0.08% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -161,612 | -100.0% | -0.08% | – |
| HLXA | Exit | HELIX ACQUISITION CORP | $0 | – | -750,000 | -100.0% | -0.11% | – |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -975,000 | -100.0% | -0.14% | – |
| INMD | Exit | INMODE LTD | $0 | – | -124,999 | -100.0% | -0.30% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -7,582,396 | -100.0% | -2.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.